BlackDoctor: Not being invited is greatest barrier to Black patient participation in clinical trials
Information about this website: Following the March 2026 merger of Patient Advocate Foundation and the PAN Foundation, this website is now a part of Patient Advocate Foundation and remains active during our website transition.
Where to find information during our transition:
- About the merged organization: uniting.patientadvocate.org
- Financial assistance: totalassist.org
- Additional direct patient services and resources: patientadvocate.org
- Education: panfoundation.org and education.patientadvocate.org
- Clinical trials education: clinicaltrials.panfoundation.org
- Advocacy: npaf.org
- Research: patientinsightinstitute.org
Clinical trials have historically underrepresented Black people and other people of color. This lack of representation is concerning because these communities often experience higher rates and incidences of the diseases being studied.
An article in BlackDoctor.org explored data published by the PAN Foundation’s Center for Patient Research which found that while 83 percent of respondents identifying as Black and people of color had a positive view of clinical trials, very few respondents have been approached by their health care providers with information about clinical trial enrollment.
Health disparities among Black people are rooted in systemic issues, including socioeconomic factors, limited access to quality health care, and a historical mistrust in medical institutions. These disparities are exacerbated by factors like discrimination, inadequate insurance coverage, and environmental conditions, leading to higher rates of chronic illnesses and poorer health outcomes in these communities, the BlackDoctor.org article states.
Mentioned in the article, PAN’s Opening Doors to Clinical Trials initiative aims to empower individuals in underrepresented communities to advocate for themselves and learn more about how they might participate in medical research advances.